Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 12.46M
March 31, 2026 -3.454M
December 31, 2025 -5.430M
September 30, 2025 -6.366M
June 30, 2025 35.48M
March 31, 2025 -0.4082M
December 31, 2024 45.76M
September 30, 2024 1.344M
June 30, 2024 1.833M
March 31, 2024 10.28M
December 31, 2023 72.26M
September 30, 2023 -0.3931M
June 30, 2023 -2.876M
March 31, 2023 -0.9183M
December 31, 2022 -0.8118M
September 30, 2022 33.04M
June 30, 2022 2.037M
March 31, 2022 -0.361M
December 31, 2021 73.21M
September 30, 2021 -3.113M
June 30, 2021 0.1692M
March 31, 2021 -0.8121M
December 31, 2020 20.16M
September 30, 2020 24.19M
June 30, 2020 20.89M
Date Value
March 31, 2020 -8.898M
December 31, 2019 -4.503M
September 30, 2019 -1.206M
June 30, 2019 -3.162M
March 31, 2019 1.630M
December 31, 2018 52.39M
September 30, 2018 388.05M
June 30, 2018 -7.051M
March 31, 2018 -11.58M
December 31, 2017 -10.30M
September 30, 2017 -9.816M
June 30, 2017 -7.501M
March 31, 2017 -8.615M
December 31, 2016 -10.44M
September 30, 2016 -9.244M
June 30, 2016 -9.566M
March 31, 2016 -10.45M
December 31, 2015 -20.09M
September 30, 2015 -5.630M
June 30, 2015 -6.573M
March 31, 2015 -7.153M
December 31, 2014 -19.06M
September 30, 2014 -240.08M
June 30, 2014 -2.948M
March 31, 2014 -3.382M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 23.00M
Corcept Therapeutics, Inc. 42.14M
Veru, Inc. -6.988M
Johnson & Johnson 210.00M
Eli Lilly & Co. 7.095B